logo
Southeast Asia pharma market set to outgrow global average

Southeast Asia pharma market set to outgrow global average

Focus Malaysia2 days ago
SOUTHASIA Asia (SEA) presents a substantial future prospect for the pharmaceutical market. Its projected growth rate significantly outpaces the global average and other major established markets.
As of calendar year 2024 (CY24), global total market size for pharmaceuticals is estimated at USD1.5 tri. In comparison, SEA's total market size is estimated at USD27 bil.
The significant growth for SEA indicates that ASEAN is a prime growth engine for the global pharmaceutical industry. This makes it an attractive destination for investment and market expansion.
The Philippines and Malaysia show steady growth in a biosimilar export potential, reaching USD 111 mil and USD 70 mil respectively by 2027.
Malaysia's growth, though robust, is relatively smaller in absolute terms compared to Thailand, Vietnam, and Indonesia.
However, companies like Duopharma and Pharmaniaga are actively developing Halal-certified biosimilars.
Overall, biosimilars is an untapped potential due to increasing healthcare demands and cost pressure.
'We believe that investing in local manufacturing of biosimilars can open avenues for SEA countries to export,' said MBSB Research.
Countries that prioritise and invest in local biosimilar production are likely to become stronger exporters in this field.
This aligns with the broader trends of high pharmaceutical market growth in SEA driven by demographics, NCDs, and the increasing sophistication of healthcare systems, all of which necessitate tailored and creative market strategies.
Malaysia's pharmaceutical sector boasts a strong and strategically recognized local manufacturing base that significantly contributes to medicine security, especially for generics and essential medicines.
While Malaysia demonstrates capabilities in exporting to highly regulated markets like the USA, it remains heavily reliant on imports for patented drugs, biologics, vaccines, and key APIs.
The main challenge for Malaysia lies in bridging this gap by further boosting local R&D, attracting more sophisticated manufacturing capabilities, and strengthening its position in the global pharmaceutical value chain beyond just generics.
79% of total volume of generic medicines and 47% of items listed in National Essential Medicines List (NEML) are locally produced.
However, most drugs, notably patented medicaments, immunoglobulins, human vaccines and insulins, are still dependent on imports.
Malaysia consistently shows widening trade deficit underscores Malaysia's high reliance on imported pharmaceuticals.
While local production is strong in generics, the country still depends heavily on foreign sources for innovative, patented, and specialised medicines.
This reinforces the government's strategic focus on local manufacturing and technology transfer to enhance medicine security and reduce import dependency in the long run.
The overall trend in the regional and local pharmaceutical market suggests that both domestic and foreign investors will see growing opportunities in Malaysia.
The 51% FDI / 49% DDI ratio suggests a healthy balance between local commitment, and global capital and expertise.
FDI indicates that Malaysia is highly attractive to foreign pharmaceutical companies, bringing in capital, technology, and global best practices, while DDI signifies robust local entrepreneurship and investment from Malaysian companies, demonstrating confidence in the domestic market and capabilities.
We opine that the untapped drug manufacturing ecosystem will continue to follow the megatrend of new innovative drugs – including biologics, biosimilars and cell & gene therapy drugs – and open more opportunities for Malaysia to be a major healthcare hub in the region.
While direct pharmaceutical exports from Malaysia to the US might face immediate headwinds from tariffs, the broader impact on Malaysia's healthcare subsector could come from indirect effects on global pharmaceutical supply chains and procurement costs.
This would affect the affordability and availability of medicines within Malaysia for all citizens and healthcare providers.
The Malaysian government and industry players are already responding by prioritizing supply chain diversification and exploring domestic production enhancements to mitigate these risks.
Meanwhile, we believe a multi-pronged approach involving government action, industry adaptation, and consumer awareness will be crucial.
Overall, we maintain positive on the healthcare sector. The pharmaceutical market is fundamentally driven by robust demographic trends, which naturally increases the demand for healthcare services and medicines. —July 23, 2025
Main image: Daily Sabah
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

India's leather, footwear exports to UK could exceed USD 900 mn as FTA opens new opportunities for small artisans
India's leather, footwear exports to UK could exceed USD 900 mn as FTA opens new opportunities for small artisans

Malaysia Sun

time16 hours ago

  • Malaysia Sun

India's leather, footwear exports to UK could exceed USD 900 mn as FTA opens new opportunities for small artisans

New Delhi [India], July 24 (ANI): India's leather and footwear exports to the UK could exceed USD 900 million, marking a major leap forward for the sector. This growth is expected as the India-UK Free Trade Agreement (FTA) opens up new opportunities for small artisans and businesses across the country. The FTA offers duty-free access to the UK's USD 23 billion market, giving Indian Micro, Small and Medium Enterprises (MSMEs) a strong advantage over other countries like Bangladesh, Cambodia, and Pakistan in labour-intensive sectors such as leather and footwear, textiles and clothing, gems and jewellery, furniture, and sports goods. This is expected to unlock vast new opportunities for Indian exporters. The agreement is also likely to enhance the financial stability of small businesses, particularly for artisans, women entrepreneurs, and craftsmen. By providing them with access to a large market like the UK, the FTA enables these groups to support their families and communities while becoming key players in global value chains. The FTA includes provisions that encourage MSMEs to utilise digital tools, adopt e-commerce, and transition to more sustainable production methods. These changes will not only enhance efficiency but also enable Indian products to reach a broader international audience. With stronger intellectual property rights (IPR) and geographical indication (GI) protections included in the deal, MSMEs' unique and traditional products are expected to gain better recognition globally. This can increase the value of their goods in foreign markets. Increased export opportunities in labour-intensive industries, such as textiles, leather, and footwear, are expected to raise demand for skilled artisans in hubs like Tirupur and Kanpur. This, in turn, could create more jobs and boost local economies. As exports rise, private sector players in India are also expected to increase their production capacity. This is likely to lead to increased employment and improved income for individuals involved in these industries. India is now well-positioned to become one of the top three suppliers of textiles, leather, and footwear to the UK. SMEs across different states are expected to expand their production, hire more workers, and contribute to the development of their communities. In addition to leather and textiles, MSMEs in other sectors, such as marine products, agriculture, pharmaceuticals, chemicals, electronics, engineering, oilseeds, alcoholic beverages, and soft commodities, are also expected to benefit from the FTA by increasing production and innovation. (ANI)

New ESG association to drive sustainability practices
New ESG association to drive sustainability practices

The Star

time19 hours ago

  • The Star

New ESG association to drive sustainability practices

SEAM vice-president Alex Yeoh (left) and founding president Liang Yit Wen KUALA LUMPUR: The Sustainability & ESG Association Malaysia (SEAM) had its soft launch today with the aim to drive meaningful environmental, social, and governance (ESG) adoption through real-world implementation. According to the association's statement, its cornerstone is the IDEA-C Framework – a structured approach designed to help corporates identify ESG opportunities, diagnose gaps, engineer solutions, activate change, and communicate measurable impact. "SEAM fills a critical market gap by connecting ESG-certified professionals and solution providers with businesses seeking verified, scalable sustainability practices," it said. SEAM's membership is open to ESG-certified professionals, consultants, implementors, compliant corporates, and relevant institutional alliances. The association will also work closely with stakeholders such as regulators, certification bodies, and capital market players. "We provide a trusted, neutral platform that brings both sides together, helping businesses take action confidently, and enabling solution providers to scale their impact. "Our aim is to turn ESG from ambition into execution, and from pledges into measurable value," said SEAM founding president Liang Yit Wen.

Nestle Malaysia's Q2 earnings jumps 20pct on 9.5pct revenue increase
Nestle Malaysia's Q2 earnings jumps 20pct on 9.5pct revenue increase

New Straits Times

timea day ago

  • New Straits Times

Nestle Malaysia's Q2 earnings jumps 20pct on 9.5pct revenue increase

KUALA LUMPUR: Nestlé (Malaysia) Bhd posted a 20 per cent increase in net profit to RM112.1 million for the second quarter ended June 30, 2025, up from RM93.6 million in the same period last year, supported by higher sales and effective cost control. Its revenue for the quarter grew 9.5 per cent to RM1.67 billion from RM1.52 billion previously, driven by steady domestic demand and resilient export performance. In a Bursa Malaysia filing, the company said this reflected its strong global position, particularly as the largest Halal manufacturing hub within the Nestlé Group. It added that continued emphasis on quality, taste, and nutritional value helped maintain strong brand loyalty amid a fast-evolving market. Nestlé Malaysia declared an interim dividend of 70 sen per share, unchanged from the previous year, to be paid on Oct 2. Chief executive officer Juan Aranols said the company is confident in its ability to sustain strong growth momentum and achieve profit recovery in the second half of 2025 (2H25). "We are mindful and vigilant of the geopolitical uncertainties that may impact the business environment in Malaysia. "Despite these ongoing uncertainties, we are committed to upholding our promise to provide great-tasting and nutritious Halal products, under Malaysians' favourite and most trusted brands," he said. Aranols said the company will continue to accelerate its digital transformation and drive efficiencies to support brand investments and innovation, aiming to reinforce its market leadership. This, he added, will be guided by a deep understanding of Malaysian consumer values and a firm commitment to making a positive impact on communities and the environment.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store